{"id":"W2935816391","doi":"10.1186/s40425-019-0538-8","title":"Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Hyundai Hope On Wheels; National Cancer Institute; Stand Up To Cancer; U.S. Department of Health and Human Services; National Institutes of Health; University of Wisconsin Carbone Cancer Center; ECOG-ACRIN Cancer Research Group; Midwest Athletes Against Childhood Cancer; American College of Radiology Imaging Network; U.S. Public Health Service; St. Baldrick's Foundation; American Association for Cancer Research; University of Wisconsin-Madison","keywords":"Rituximab; Follicular lymphoma; Human leukocyte antigen; Follicular phase; Medicine; Immunology; Lymphoma; Internal medicine; Antigen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002550596,0.0002379913,0.0004724933,0.000130697,0.000248957,0.00006739495,0.00009719668,0.0001778356,0.000346663],"category_scores_gemma":[0.00001799497,0.0001609108,0.0001029509,0.00004898397,0.000118687,0.0003378331,0.00002895078,0.0002209211,0.000002934659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006790545,"about_ca_system_score_gemma":0.000046453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001339893,"about_ca_topic_score_gemma":0.00002289615,"domain_scores_codex":[0.9989904,0.00004917739,0.0004184859,0.0002320747,0.00004614883,0.0002637008],"domain_scores_gemma":[0.9990953,0.000103478,0.0003973058,0.0001671906,0.000208175,0.00002859021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006917642,0.0002703784,0.1839472,0.0001109021,0.001444464,4.160824e-7,0.002210283,0.000002131457,0.6223994,0.00003570197,0.001214013,0.1814475],"study_design_scores_gemma":[0.06149268,0.005007079,0.4001122,0.0006425856,0.0002210567,0.0002845455,0.001517008,0.0001282189,0.1623482,0.0003148951,0.3670127,0.0009187121],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763623,0.02050924,0.0002357847,0.0003269505,0.002060175,0.0004147225,0.00001801879,0.00001538575,0.00005745903],"genre_scores_gemma":[0.9913491,0.003210088,0.0001244715,0.0004505042,0.00004412669,0.0000248723,0.00001833536,0.00004055465,0.004737956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4600512,"threshold_uncertainty_score":0.6561754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00666545812998804,"score_gpt":0.2356607765638207,"score_spread":0.2289953184338327,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}